Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|December 1, 1989
In vivo oxidative cleavage of a pyridine-carboxylic acid ester metabolite of nifedipineT Funaki, P A Soons, F P Guengerich, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1993
Simultaneous determination of a new anticancer drug galocitabine and its metabolites in blood by high-performance liquid chromatographyT Funaki, H Onodera, K Ogawa, et al.
Cell Structure and Function|February 1, 1996
Identification and characterization of a 230-kDa Golgi-associated protein recognized by autoantibodies from a patient with HBV hepatitisT Funaki, T Fujiwara, H S Hong, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1994
The disposition of the tolcapone 3-O-methylated metabolite is affected by the route of administration in ratsT Funaki, H Onodera, N Ushiyama, et al.
Physiology & Behavior|August 10, 2021
Eating and wheel running across the estrous cycle in rat lines selectively bred on a taste phenotypeNancy K Dess, Alexis T Funaki, Benjamin G Fanson, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1995
Lack of an effect of Madopar on the disposition of tolcapone and its 3-O-methylated metabolite in ratsT Funaki, H Onodera, N Ushiyama, et al.
Journal of Biochemistry|November 1, 1986
Immunological characterization of human vitronectin and its binding to glycosaminoglycansT Akama, K M Yamada, N Seno, et al.
International Journal of Oncology|September 20, 2002
Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinomaK Kurokohchi, S Watanabe, T Masaki, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2010
Pharmacokinetic study of the oral administration of procaterol hydrochloride hydrate 50 µg in healthy adult Japanese menH Kobayashi, M Masuda, E Kashiyama, et al.
AJNR. American Journal of Neuroradiology|September 14, 2019
Identification of the Bleeding Point in Hemorrhagic Moyamoya Disease Using Fusion Images of Susceptibility-Weighted Imaging and Time-of-Flight MRAA Miyakoshi, T Funaki, Y Fushimi, et al.
Pageof 3